Ocean Bio-Chem Competitors

Cadiz (NASDAQ:CDZI) and Ocean Bio-Chem (NASDAQ:OBCI) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Profitability

This table compares Cadiz and Ocean Bio-Chem's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cadiz and Ocean Bio-Chem's top-line revenue, earnings per share and valuation.

Ocean Bio-Chem has higher revenue and earnings than Cadiz.

Risk and Volatility

Cadiz has a beta of -0.12, indicating that its share price is 112% less volatile than the S&P 500. Comparatively, Ocean Bio-Chem has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Cadiz and Ocean Bio-Chem, as reported by MarketBeat.com.

Insider and Institutional Ownership

18.3% of Cadiz shares are owned by institutional investors. Comparatively, 11.1% of Ocean Bio-Chem shares are owned by institutional investors. 2.1% of Cadiz shares are owned by insiders. Comparatively, 62.0% of Ocean Bio-Chem shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Ocean Bio-Chem beats Cadiz on 7 of the 9 factors compared between the two stocks.

Ocean Bio-Chem (NASDAQ:OBCI) and HF Foods Group (NASDAQ:HFFG) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Profitability

This table compares Ocean Bio-Chem and HF Foods Group's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Ocean Bio-Chem and HF Foods Group's top-line revenue, earnings per share (EPS) and valuation.

HF Foods Group has higher revenue and earnings than Ocean Bio-Chem.

Risk & Volatility

Ocean Bio-Chem has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, HF Foods Group has a beta of 1.66, meaning that its stock price is 66% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ocean Bio-Chem and HF Foods Group, as provided by MarketBeat.

Insider and Institutional Ownership

11.1% of Ocean Bio-Chem shares are owned by institutional investors. Comparatively, 14.0% of HF Foods Group shares are owned by institutional investors. 62.0% of Ocean Bio-Chem shares are owned by company insiders. Comparatively, 32.5% of HF Foods Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Ocean Bio-Chem beats HF Foods Group on 6 of the 10 factors compared between the two stocks.

Ocean Bio-Chem (NASDAQ:OBCI) and Novus Capital (NASDAQ:NOVS) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Profitability

This table compares Ocean Bio-Chem and Novus Capital's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Ocean Bio-Chem and Novus Capital's top-line revenue, earnings per share (EPS) and valuation.

Ocean Bio-Chem has higher revenue and earnings than Novus Capital.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ocean Bio-Chem and Novus Capital, as provided by MarketBeat.

Insider and Institutional Ownership

11.1% of Ocean Bio-Chem shares are owned by institutional investors. Comparatively, 43.8% of Novus Capital shares are owned by institutional investors. 62.0% of Ocean Bio-Chem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Ocean Bio-Chem beats Novus Capital on 5 of the 6 factors compared between the two stocks.

Ocean Bio-Chem (NASDAQ:OBCI) and Calyxt (NASDAQ:CLXT) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability.

Risk & Volatility

Ocean Bio-Chem has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Calyxt has a beta of 2.36, meaning that its stock price is 136% more volatile than the S&P 500.

Profitability

This table compares Ocean Bio-Chem and Calyxt's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Ocean Bio-Chem and Calyxt's top-line revenue, earnings per share (EPS) and valuation.

Ocean Bio-Chem has higher revenue and earnings than Calyxt.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ocean Bio-Chem and Calyxt, as provided by MarketBeat.

Calyxt has a consensus price target of $9.00, suggesting a potential downside of 6.74%. Given Calyxt's higher probable upside, analysts plainly believe Calyxt is more favorable than Ocean Bio-Chem.

Insider and Institutional Ownership

11.1% of Ocean Bio-Chem shares are owned by institutional investors. Comparatively, 23.8% of Calyxt shares are owned by institutional investors. 62.0% of Ocean Bio-Chem shares are owned by company insiders. Comparatively, 2.3% of Calyxt shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Ocean Bio-Chem beats Calyxt on 7 of the 12 factors compared between the two stocks.

Ocean Bio-Chem (NASDAQ:OBCI) and NewAge (NASDAQ:NBEV) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends.

Volatility & Risk

Ocean Bio-Chem has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, NewAge has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500.

Profitability

This table compares Ocean Bio-Chem and NewAge's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Ocean Bio-Chem and NewAge's gross revenue, earnings per share (EPS) and valuation.

Ocean Bio-Chem has higher earnings, but lower revenue than NewAge.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Ocean Bio-Chem and NewAge, as provided by MarketBeat.com.

NewAge has a consensus price target of $4.50, suggesting a potential upside of 55.71%. Given NewAge's higher probable upside, analysts clearly believe NewAge is more favorable than Ocean Bio-Chem.

Insider & Institutional Ownership

11.1% of Ocean Bio-Chem shares are held by institutional investors. Comparatively, 21.4% of NewAge shares are held by institutional investors. 62.0% of Ocean Bio-Chem shares are held by company insiders. Comparatively, 4.2% of NewAge shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Ocean Bio-Chem beats NewAge on 7 of the 11 factors compared between the two stocks.

Ocean Bio-Chem (NASDAQ:OBCI) and Landec (NASDAQ:LNDC) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends.

Insider & Institutional Ownership

11.1% of Ocean Bio-Chem shares are held by institutional investors. Comparatively, 88.9% of Landec shares are held by institutional investors. 62.0% of Ocean Bio-Chem shares are held by company insiders. Comparatively, 11.9% of Landec shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Ocean Bio-Chem and Landec's net margins, return on equity and return on assets.

Volatility & Risk

Ocean Bio-Chem has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, Landec has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Ocean Bio-Chem and Landec, as provided by MarketBeat.com.

Landec has a consensus price target of $12.75, suggesting a potential upside of 13.54%. Given Landec's higher probable upside, analysts clearly believe Landec is more favorable than Ocean Bio-Chem.

Valuation & Earnings

This table compares Ocean Bio-Chem and Landec's gross revenue, earnings per share (EPS) and valuation.

Ocean Bio-Chem has higher earnings, but lower revenue than Landec.

Summary

Ocean Bio-Chem beats Landec on 7 of the 12 factors compared between the two stocks.